Organized by Genome Canada
Antimicrobial resistance (AMR) is a global health threat. Recent studies indicate that drug resistant microbes could cause the deaths of 10 million people a year and cost the global economy $60 trillion to $100 trillion by 2050 indicated Jim O’Neill, a former Goldman Sachs economist. The need to find solutions is a national priority. Canada, through its federal action plan, is taking steps to prevent, limit, and control the emergence and spread of AMR, with a focus on surveillance, stewardship, and innovation.
The World Health Organization stated antimicrobial resistance has become one of the most serious global health threats of modern times and urges governments to improve surveillance and research and that policy makers enable change by promoting appropriate use of antibiotics, increasing awareness, and rewarding innovation.
Based on the above, policy options will be explored on how Canada can be a leader in pathogen surveillance utilizing genomic analysis, furthering the use of genomic databases to assess the emergence and spread of AMR, and innovative genomic tools to diagnose and treat microbial infection quickly and efficiently.
This workshop is part of Genome Canada’s GPS series "Where Genomics, Public Policy and Society Meet." The session will facilitate a dialogue between researchers, policy-makers and industry interested in GE3LS (Genomics and its Ethical, Economic, Environmental, Legal, and Social aspects). A draft policy brief on antimicrobial resistance reviewing the context, issues of concern relevant to Canadians as well as innovative genomic solutions and policy options to help manage this global health threat will be presented. Furthermore, invited commentators from academia, government and industry will discuss the policy options examined in this brief.